(Press-News.org) BOSTON, Mass. and PORTLAND, Maine, January 27, 2026// Boston University (BU) today announced it has been awarded a $2 million research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The funding will support a clinical study evaluating motor and cognitive factors associated with changes in walking for people with Parkinson’s disease who use MedRhythms’ MOVIVE (MR-005), a safe, use-at-home medical device that delivers rhythmic auditory stimulation (RAS) to support gait rehabilitation and motor function.
This study was funded through The Michael J. Fox Foundation’s Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease research program, which supports clinical research focused on addressing the wide variability of gait challenges experienced by people with Parkinson’s disease. The program prioritizes studies like this one that seek to better understand the motor and cognitive contributors to gait impairment and to inform more tailored approaches to assessment and intervention.
“Walking impairments are among the most common and disabling symptoms of Parkinson’s disease,” said Dr. Terry Ellis, Professor and Director of the Center for Neurorehabilitation at Boston University and the study’s Lead Investigator. “This award reflects The Michael J. Fox Foundation’s commitment to accelerating scalable, evidence-based approaches, like rhythmic auditory stimulation (RAS), for people living with PD.”
MOVIVE delivers personalized, adaptive, music-based RAS that responds in real time to users’ walking patterns using shoe-worn gait sensors and algorithm-driven software. By enabling autonomous use in the home, MOVIVE is designed to expand access to neurorehabilitation and support ongoing motor function.
This study will investigate motor and cognitive responses to a three-month, at-home intervention with MOVIVE utilizing a comprehensive set of gait, mobility, and cognitive assessments. Innovative mobile brain imaging using functional near-infrared spectroscopy (fNIRS) will examine neural substrates that underlie changes in gait performance in a cohort of participants to explore brain-based markers of cognitive load and individual variability in response to RAS-based gait training.
“MedRhythms is honored to support this important study funded by The Michael J. Fox Foundation and led by Dr. Terry Ellis of Boston University, a leader in the field” said Brian Harris, Co-Founder and Chief Scientific Officer at MedRhythms. “We look forward to the impact that this study may have on advancing important care for people living with Parkinson’s disease”
Boston University and MedRhythms have a longstanding research collaboration, including prior feasibility studies of MOVIVE and related technologies. These earlier investigations demonstrated promising outcomes in stride length, walking speed, and gait automaticity.
This study plans to enroll 160 participants at three academic medical centers: Boston University, Washington University in St. Louis, and University of Utah. MedRhythms will provide devices and technical support for the study at no cost to the project.
For more information about BU’s Center for Neurorehabilitation please visit https://www.bu.edu/neurorehab/our-team/
For full safety and prescriber information, visit movive.com
About Boston University Sargent College of Health & Rehabilitation Sciences
Founded in 1839, Boston University (BU) is a leading research institution with 17 schools and colleges and more than 38,000 students from over 140 countries. Sargent College of Health & Rehabilitation Sciences includes 92 full-time faculty and 1,900 full-time students. The college is recognized globally for advancing health and well-being through translational research, professional training, and the transformation of clinical practice via integrated research centers and partnerships.
About MedRhythms
MedRhythms is pioneering evidence-based neurorehabilitation for people with neurologic injury or disease via the world’s first prescription music platform. InTandem® and MOVIVE™, deliver rhythmic auditory stimulation (RAS) to support walking and rehabilitation in chronic stroke and Parkinson’s disease (PD). Reimbursable by Medicare, commercial insurance/Medicare Advantage, and the VA. MedRhythms is headquartered in Portland, Maine. For more information, visit www.medrhythms.com.
For Media Inquiries: Please contact BU@PR.edu
END
Boston University receives grant from the Michael J. Fox foundation to study mechanisms of gait improvement in Parkinson’s disease
2026-01-27
ELSE PRESS RELEASES FROM THIS DATE:
Trust in PhD advisor predicts a good grad school experience
2026-01-27
The advisor-advisee relationship is central to most doctoral education models. Yet not all students trust their advisors. Danfei Hu, Jonathan E. Cook, and colleagues sought to examine the importance of this relationship to success and wellbeing in graduate school. The authors focused on the first year of graduate school, a time in which PhD students adapt to their role as scholars and in which large numbers of students drop out. In a prospective longitudinal study of 558 incoming PhD students, primarily in STEM fields, at three US research universities, the authors found that PhD ...
Engineering and the quest for peace
2026-01-27
Engineering can create weapons systems or systems for defense and wellbeing. But can engineering create peace? In a Perspective, Guru Madhavan and colleagues propose an expansive mode of engineering practice that seeks to reduce conflict. In a world where the technical choices about pumping stations for transboundary water conveyance projects can become tense diplomatic questions, engineering for peace requires the competence to build systems that work as intended, the capability to foresee how such systems might be used or misused, ...
Insilico Medicine and Qilu Pharmaceutical reach near $120 million drug development collaboration to accelerate novel cardiometabolic therapies
2026-01-27
Jan 27, 2026 -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center, today announced a strategic partnership on innovative drug development, leveraging Insilico’s proprietary Pharma.AI platform to jointly develop small molecule inhibitors, focusing on specific targets for cardiometabolic disease management.
According to the agreement, Insilico Medicine will utilize its proprietary Pharma.AI platform to focus on the design and optimization ...
Chungnam National University develops AI model to accelerate defect-based material design
2026-01-27
Across the physical world, many intricate structures form via symmetry breaking. When a system with inherent symmetry transitions into an ordered state, it can form stable imperfections known as topological defects. Such defects are found everywhere, from the large-scale structure of the universe to everyday materials, making them a powerful way to study how order emerges in complex systems.
We have a tool to study these defects: nematic liquid crystals. In these materials, molecules can rotate freely while remaining roughly aligned, providing a clear and controllable ...
Identification of the central pathological substrate of bipolar disorder as paraventricular thalamic nucleus
2026-01-27
Bipolar disorder (BD) is a major mental disorder, affecting 1% of the global population. Patients suffering from BD frequently experience manic and depressive episodes, which disrupt interpersonal relationships and social confidence. While conventional therapies can mitigate the symptoms for some patients, they are also associated with adverse effects and treatment resistance in many, highlighting the urgent need for pathology-driven diagnosis and therapeutic intervention.
The thalamus, especially the paraventricular ...
A new route to synthesize multiple functionalized carbon nanohoops
2026-01-27
The field of nanomaterials is witnessing a transformative shift at the intersection of organic chemistry and molecular engineering. Among the most promising molecular structures are carbon nanohoops, of which [n]cycloparaphenylenes ([n]CPPs) are a representative example.
These ring-shaped structures represent the smallest possible slices of carbon nanotubes, which themselves are a widely renowned material of the 21st century.
Given that their structures can, in principle, be precisely tuned at the atomic level, nanohoops hold great potential as molecular components for next-generation optoelectronic ...
Integrated smart contact lens technology for real-time intraocular pressure monitoring
2026-01-27
Glaucoma is a leading cause of blindness among people who are unable to monitor and manage their intraocular pressure (IOP) daily. The current tools for IOP measurement are not portable, convenient, easily accessible, or capable of continuous (24/7) monitoring. These limitations in existing IOP devices are a major contributor to inadequate ocular health management in glaucoma patients. This mismanagement could result in severe and irreparable problems for patients.
This problem is particularly concerning, considering that one of the factors behind increased IOP is age. As the global population ...
New Boston University study identifies CTE as cause of dementia
2026-01-27
EMBARGOED by Alzheimer’s & Dementia until 7 a.m., ET, Tuesday, Jan. 27, 2026
Contact: Gina DiGravio, 617-358-7838, ginad@bu.edu
New Boston University Study Identifies CTE as Cause of Dementia
Researchers found those with advanced CTE had four times increased odds for having dementia
Boston–The largest study of its kind from the Boston University CTE Center reveals that chronic traumatic encephalopathy (CTE) should be recognized as a new cause of dementia.
The research, published online today in Alzheimer’s & Dementia: The Journal of the Alzheimer’s ...
Applied physics researchers explore impact of mathematically structured sound to selectively interact with cells.
2026-01-27
New York, NY — Researchers at AppliedPhysics.org have published an exploratory study in Biosystems examining whether mathematical acoustic signal structure can influence cellular response independent of intensity. The work investigates Bioacoustics Signaling, focusing on quasiperiodic acoustic signals derived from Fibonacci sequences with potential relevance to cancer research. It reports preliminary evidence that cells respond most strongly at different wavelength regimes, suggesting that acoustic selectivity may be achievable through signal design rather ...
New study redefines our understanding of how memory works
2026-01-27
A new study into how different parts of memory work in the brain has shown that the same brain areas are involved in retrieving different types of information, the findings could redefine how memory is understood and studied.
Researchers from the School of Psychology at the University of Nottingham and the Cognition and Brain Sciences Unit at the University of Cambridge have examined episodic and semantic memory, combining task based and fMRI data and have shown that there is no difference in neural activity between successful semantic and episodic retrieval. The findings have been published today in Nature Human ...